![Nilu Shaikh](/sites/default/files/styles/medium/public/2021-03/Nilufer-Shaikh-200x200.png?itok=NNcEXzKt)
Nilufer focuses her practice on domestic and cross-border M&A transactions, joint ventures, restructurings and minority investments across a variety of industry sectors, including health care, life sciences, information technology, software and consumer goods. She has extensive experience representing private equity firms and their portfolio companies, as well as other private and publicly owned strategic buyers and sellers. Nilufer also has represented venture capital firms and emerging growth companies in debt and equity financing transactions. She has led founders and families in exit transactions, as well as counseled family offices as buyers in global corporate carve-outs.
In addition to her transactional practice, Nilufer provides general corporate counseling, advising senior management and boards of directors in areas such as corporate governance, strategic matters, contract negotiation and other commercial issues. She advises investment banks and advisory firms in connection with their solvency, fairness and other opinion engagements.
Nilufer is actively involved in pro bono matters and has represented nonprofit and educational institutions. She has assisted a New York-based special education school in its contracting compliance, counseled the board of directors of a 501(c)(3) organization aimed at increasing female participation in the asset management industry, and advised a global social enterprise on restructuring its non-U.S. operations. She has also represented clients in asylum proceedings before immigration court and U-visa status filings and participated in election protection efforts.
Nilufer is an adjunct professor at American University Washington College of Law. She is also a member of the working group of the Committee of Mergers and Acquisitions of the American Bar Association that produces the Private Target Mergers & Acquisitions Deal Points Study, a widely cited resource on key M&A deal terms.